Studying a new balloon treatment for small heart arteries
Part of Heart & circulation clinical trials.
This trial tests a special balloon coated with medicine to treat blocked small arteries in the heart. It may help people who have new blockages and are getting a procedure to open those arteries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 19 years old
- You have a new blockage in a small heart artery that is less than 3.0 mm in width
- Your doctor plans to use the GENOSS DCB balloon during your procedure
- You are not pregnant or planning to become pregnant during the study
- You are expected to live more than one year
- You are not in shock or at very high risk of dying right now
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is looking at how well a special balloon that releases medicine works to open blocked heart arteries. It may help people who have not had a stent placed in the same spot before.
This study tests a drug-coated balloon (DCB) that releases two medicines (sirolimus and paclitaxel) to open blocked small heart arteries. It may help people with stable chest pain or recent, controlled heart events who have a narrowed small vessel.
This trial is testing a special balloon coated with medication to treat newly formed blockages in the heart's arteries. The medication may help keep the artery open after the balloon opens it during a standard procedure.
This trial tests how the way a drug-coated balloon is used during a heart procedure affects outcomes for people with stable heart disease or unstable angina. It may help doctors find the best technique to keep arteries open.
This study follows adults with blocked heart arteries who are treated using a special type of balloon (drug-coated balloon) during a procedure. It aims to track real-world outcomes to better understand how well this treatment works for people with new blockages or previously treated vessel narrowing.
This trial studies a special artery treatment called DCB (drug-coated balloon) for new (de novo) blockages in people with coronary heart disease, guided by a heart scan measurement (QFR). It aims to check whether it is safe and works well to improve blood flow and reduce problems during follow-up.
Hear when a new Coronary Artery Disease(CAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.